![PDF) Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: 12-Month Outcomes from the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies PDF) Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: 12-Month Outcomes from the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies](https://i1.rgstatic.net/publication/318590981_Stellarex_Drug-Coated_Balloon_for_Treatment_of_Femoropopliteal_Disease_12-Month_Outcomes_from_the_Randomized_ILLUMENATE_Pivotal_and_Pharmacokinetic_Studies/links/5cad58af92851ccd4ac06816/largepreview.png)
PDF) Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: 12-Month Outcomes from the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies
![Study Results Confirm Safety Of Philips Stellarex .035-Inch Drug-Coated Balloon - Medical Product Outsourcing Study Results Confirm Safety Of Philips Stellarex .035-Inch Drug-Coated Balloon - Medical Product Outsourcing](https://dev.rodpub.com/images/227/368_main.jpg)
Study Results Confirm Safety Of Philips Stellarex .035-Inch Drug-Coated Balloon - Medical Product Outsourcing
![Philips introduces new 200mm and 150mm Stellarex 0.035” low-dose drug-coated balloons » Cardiology2.0 Philips introduces new 200mm and 150mm Stellarex 0.035” low-dose drug-coated balloons » Cardiology2.0](https://cardiology2.com/wp-content/uploads/2019/10/chrislandon_philips.jpg)